At5g17165 Antibody

What is At5g17165 and what cellular functions does this protein perform?

At5g17165 is a gene locus in Arabidopsis thaliana that encodes a protein involved in plant cellular processes. While specific information about this particular gene is limited in the provided search results, we can understand its research context by examining similar plant proteins. For example, the related protein ATG5 (AT5G17290) forms a conjugate with ATG12 and plays an essential role in plant nutrient recycling, complete proteolysis of chloroplast stroma proteins in senescent leaves, and degradation of damaged peroxisomes . When designing experiments with At5g17165 antibodies, researchers should first confirm the protein's expression patterns across different plant tissues and developmental stages through literature review and preliminary Western blot analyses.

What are the key considerations when selecting an At5g17165 antibody for immunological studies?

When selecting an At5g17165 antibody, researchers should evaluate several critical parameters:

• Antibody specificity: Confirm that the antibody specifically recognizes At5g17165 without cross-reactivity to related proteins.

• Clonality: Consider whether polyclonal or monoclonal antibodies better suit your experimental needs. Polyclonal antibodies, like those commonly used for plant proteins, recognize multiple epitopes and may provide stronger signals but potentially lower specificity .

• Host species: The host in which the antibody was raised affects secondary antibody selection and potential cross-reactivity in your system.

• Validated applications: Verify that the antibody has been validated for your intended applications (Western blot, immunoprecipitation, immunofluorescence, etc.) .

• Reactivity confirmation: Many plant antibodies are initially characterized using recombinant proteins, and their reactivity with endogenous proteins needs confirmation .

What are the optimal storage conditions for maintaining At5g17165 antibody viability?

To maintain antibody viability and functionality over time, follow these evidence-based storage practices:

• Store lyophilized antibodies at -20°C until reconstitution.

• After reconstitution, aliquot the antibody to avoid repeated freeze-thaw cycles, which can degrade antibody quality.

• For reconstituted antibodies, maintain storage at -20°C for long-term preservation.

• Before opening tubes, briefly centrifuge to collect any material that might adhere to the cap or sides .

• For working stocks, some antibodies may be stored at 4°C for 1-2 weeks, but confirm this with supplier documentation.

These recommendations align with standard practices for plant antibodies such as the ATG5 antibody, which requires similar storage conditions .

How should I optimize Western blot protocols for At5g17165 detection in Arabidopsis samples?

Optimizing Western blot protocols for plant proteins like At5g17165 requires specific considerations:

• Sample preparation:

  • Extract proteins using a buffer containing protease inhibitors appropriate for plant tissues

  • Include reducing agents like DTT or β-mercaptoethanol to disrupt potential disulfide bonds

• Gel selection:

  • Choose appropriate percentage acrylamide gels based on the predicted molecular weight of At5g17165

  • Consider gradient gels for better resolution if the exact size is uncertain

• Blocking optimization:

  • Test both BSA and non-fat dry milk blocking solutions, as plant proteins may exhibit different background patterns

  • Consider 3-5% blocking agent concentration for 1-2 hours at room temperature

• Antibody dilution:

  • Start with a 1:1000 dilution for primary antibody as recommended for similar plant antibodies

  • Optimize through dilution series if necessary (1:500 to 1:5000)

• Controls:

  • Include recombinant At5g17165 protein as a positive control if available

  • Use samples from Arabidopsis mutants lacking At5g17165 as negative controls

  • Consider testing for cross-reactivity with similar proteins (e.g., test whether it cross-reacts with ATG7)

What extraction protocols are most effective for isolating At5g17165 from different plant tissues?

Effective protein extraction from plant tissues requires protocols that address the unique challenges of plant material:

• General extraction buffer components:

  • 50 mM Tris-HCl (pH 7.5)

  • 150 mM NaCl

  • 1% Triton X-100 or NP-40

  • 0.5% sodium deoxycholate

  • Complete protease inhibitor cocktail

  • 1 mM PMSF added fresh

• Tissue-specific considerations:

  • Leaf tissue: Include 2% PVPP to remove phenolic compounds and 5 mM DTT to prevent oxidation

  • Root tissue: Increase detergent concentration to 2% and include additional washing steps

  • Floral tissue: Add 10% glycerol to stabilize proteins

• Homogenization methods:

  • Liquid nitrogen grinding with mortar and pestle provides excellent results but is labor-intensive

  • Bead mill homogenizers offer efficient processing for multiple samples

  • For recalcitrant tissues, combined freezing and mechanical disruption yields best results

• Post-extraction processing:

  • Centrifuge at 15,000g for 15 minutes at 4°C to remove debris

  • Filter supernatant through cheesecloth for particularly fibrous tissues

  • Consider a second centrifugation step at higher speed (20,000g) for clearer extracts

Each tissue type may require protocol adjustments to maximize protein yield while minimizing interfering compounds.

How can I validate antibody specificity for At5g17165 in my experimental system?

Validating antibody specificity is crucial for reliable experimental results. For At5g17165 antibody, implement these validation strategies:

• Genetic validation:

  • Compare immunoblot signals between wild-type plants and knockout/knockdown lines lacking At5g17165

  • Use CRISPR-generated mutants as gold-standard negative controls

• Molecular validation:

  • Perform immunoprecipitation followed by mass spectrometry to confirm target identity

  • Conduct peptide competition assays using the immunizing peptide to block specific binding

• Cross-reactivity assessment:

  • Test against recombinant related proteins (similar to testing ATG5 antibody against ATG7)

  • Examine signal in tissues with known differential expression patterns

• Immunolocalization consistency:

  • Compare localization patterns using multiple antibodies targeting different epitopes of At5g17165

  • Correlate with fluorescent protein fusion localization patterns

• Signal depletion test:

  • Pre-adsorb the antibody with recombinant At5g17165 protein

  • Observe elimination of specific signals while non-specific signals remain

Document all validation experiments thoroughly, as they form the foundation for interpreting subsequent experimental results.

How can I employ At5g17165 antibodies in co-immunoprecipitation studies to identify interaction partners?

Co-immunoprecipitation (Co-IP) with At5g17165 antibodies allows identification of protein interaction networks:

• Pre-experimental considerations:

  • Confirm antibody suitability for immunoprecipitation applications

  • Design appropriate crosslinking strategies if interactions are transient

  • Select lysis buffers that preserve protein-protein interactions (typically milder detergents)

• Protocol optimization:

  • Crosslink antibody to beads (protein A/G) to prevent antibody contamination in eluates

  • Include appropriate controls (IgG control, lysate from knockout plants)

  • Consider native vs. denaturing conditions based on interaction characteristics

• Analytical approaches:

  • Western blot for suspected interaction partners

  • Mass spectrometry for unbiased interaction partner discovery

  • Sequential IPs (tandem IP) for improved specificity in complex lysates

• Validation strategies:

  • Reverse Co-IP using antibodies against identified partners

  • Yeast two-hybrid or split-GFP complementation assays

  • Bimolecular fluorescence complementation to confirm interactions in vivo

• Data interpretation considerations:

  • Distinguish direct vs. indirect interactions

  • Evaluate stoichiometry of interactions when possible

  • Consider tissue/condition specificity of interactions

This approach is particularly valuable for understanding protein complexes in plant signaling pathways and metabolic networks.

What considerations are important when developing a multiplex immunodetection system including At5g17165 antibody?

Developing multiplex detection systems that include At5g17165 antibody requires careful planning:

• Antibody compatibility analysis:

  • Select antibodies raised in different host species to enable distinct secondary antibody detection

  • If using multiple rabbit antibodies (common for plant proteins) , consider:

    • Direct fluorophore conjugation to primary antibodies

    • Sequential probing with complete stripping between rounds

    • Zenon labeling technology for same-species antibodies

• Signal separation strategies:

  • For fluorescence applications:

    • Choose fluorophores with minimal spectral overlap

    • Include appropriate single-stain controls for spectral unmixing

  • For chromogenic detection:

    • Select enzyme-substrate combinations with distinct colors

    • Optimize development timing for each marker

• Cross-reactivity mitigation:

  • Pre-adsorb antibodies against tissues from relevant knockout lines

  • Include excess secondary antibody blocking between detection rounds

  • Validate each antibody individually before combining

• Quantification considerations:

  • Establish dynamic range for each target protein

  • Develop standard curves using recombinant proteins when possible

  • Use internal loading controls appropriate for your experimental manipulation

• Data analysis approach:

  • Apply ratiometric analyses rather than absolute intensities

  • Consider computational methods for signal deconvolution

  • Validate multiplex results with single-plex confirmatory experiments

Multiplex approaches provide valuable insight into protein network dynamics and co-regulation patterns in plant systems.

How can phosphorylation-specific antibodies for At5g17165 be developed and validated?

Developing phosphorylation-specific antibodies for At5g17165 involves these specialized approaches:

• Phosphorylation site identification:

  • Conduct phosphoproteomic analysis of Arabidopsis tissues to identify endogenous phosphorylation sites

  • Analyze conservation of potential phosphorylation sites across species

  • Predict likely kinase recognition motifs using bioinformatic tools

• Antigen design principles:

  • Include the phosphorylated residue centrally within a 10-15 amino acid peptide

  • Consider including a C-terminal cysteine for conjugation chemistry

  • Synthesize both phosphorylated and non-phosphorylated peptides for screening and validation

• Immunization strategy:

  • Use carrier protein conjugation (KLH or BSA) to enhance immunogenicity

  • Implement screening protocols that select for phospho-specificity

  • Consider subtractive purification using non-phosphorylated peptide columns

• Validation experiments:

  • Western blot comparing phosphatase-treated vs. untreated samples

  • Peptide competition with phosphorylated and non-phosphorylated peptides

  • Testing against samples from plants treated with kinase activators/inhibitors

  • Mass spectrometry confirmation of immunoprecipitated proteins

• Application considerations:

  • Optimize sample preparation to preserve phosphorylation status (phosphatase inhibitors)

  • Include appropriate positive controls (e.g., tissues with known pathway activation)

  • Consider the dynamic nature of phosphorylation in experimental design (time courses)

Phosphorylation-specific antibodies can reveal crucial regulatory mechanisms governing At5g17165 function in plant signaling networks.

How should I address non-specific binding when using At5g17165 antibodies in plant tissue immunohistochemistry?

Reducing non-specific binding in plant immunohistochemistry requires systematic optimization:

• Fixation optimization:

  • Compare aldehyde-based fixatives vs. alcohol-based fixatives

  • Test fixation duration (2-24 hours) to balance antigen preservation and tissue penetration

  • Evaluate epitope retrieval methods if needed (heat-induced or enzymatic)

• Blocking enhancements:

  • Use plant-specific blocking solutions containing:

    • 5% normal serum from secondary antibody host species

    • 3% BSA

    • 0.3% Triton X-100

    • Optional: 0.1% plant-derived gelatin

  • Pre-adsorb primary antibodies with plant extract from knockout tissue

  • Consider avidin/biotin blocking for tissues with high endogenous biotin

• Antibody optimization:

  • Test extended dilution series (1:100 to 1:2000)

  • Compare overnight 4°C incubation vs. room temperature incubation

  • Evaluate different diluents (PBS vs. TBS vs. commercial formulations)

• Washing enhancement:

  • Increase wash duration and frequency (5-6 washes of 10 minutes each)

  • Add detergent (0.1% Tween-20) and salt (up to 500 mM NaCl) to wash buffers

  • Consider specialized wash additives like fish gelatin or powdered milk

• Controls and interpretation:

  • Include absorption controls with immunizing peptide

  • Examine secondary-only controls for each tissue type

  • Compare signal in tissues with known differential expression patterns

Careful documentation of optimization steps will facilitate reproducible protocols for At5g17165 localization studies.

What strategies can resolve contradictory results between immunological detection and transcript analysis for At5g17165?

Discrepancies between protein and transcript levels are common in biological systems and require careful analysis:

• Validation of both methodologies:

  • Confirm antibody specificity using knockout controls

  • Verify primer specificity and efficiency for transcript analysis

  • Include positive controls known to show concordance between protein and transcript

• Biological explanations exploration:

  • Post-transcriptional regulation:

    • Analyze miRNA prediction databases for potential At5g17165 regulation

    • Examine RNA-seq data for alternative splicing patterns

  • Protein stability differences:

    • Test proteasome inhibitors to assess degradation rates

    • Compare protein half-lives under different conditions

  • Translational control:

    • Perform polysome profiling to assess translation efficiency

    • Examine 5' and 3' UTR regulatory elements

• Technical considerations:

  • Temporal dynamics: Ensure protein and RNA samples are collected at appropriate intervals

  • Spatial resolution: Consider cell-type-specific vs. whole-tissue comparisons

  • Sensitivity thresholds: Evaluate detection limits of both methods

• Integrative approaches:

  • Combine techniques (e.g., translating ribosome affinity purification)

  • Implement reporter systems to track transcription and translation independently

  • Develop computational models accounting for transcription, translation, and degradation rates

• Documentation standards:

  • Record detailed experimental conditions for both protein and transcript analyses

  • Report quantification methods and normalization strategies

  • Acknowledge the potential for biological uncoupling between transcript and protein levels

This systematic approach can reveal important regulatory mechanisms governing At5g17165 expression.

How can I design quantitative assays for measuring At5g17165 protein levels in different subcellular compartments?

Developing quantitative assays for subcellular protein distribution involves these strategies:

• Biochemical fractionation approach:

  • Optimize differential centrifugation protocols for plant tissues

  • Develop marker validation panels for each subcellular fraction:

    Compartment	Marker Protein	Molecular Weight
    Cytosol	UGPase	51 kDa
    Nucleus	Histone H3	17 kDa
    Chloroplast	RbcL	55 kDa
    Mitochondria	COX II	29 kDa
    ER	BiP	78 kDa
    Peroxisome	Catalase	57 kDa

  • Quantify At5g17165 in each fraction using calibrated Western blotting

• Immunofluorescence quantitation:

  • Implement super-resolution microscopy for improved spatial resolution

  • Establish rigorous image acquisition parameters (exposure, gain, offset)

  • Develop automated image analysis workflows:

    • Segment cells into relevant compartments using marker channels

    • Measure fluorescence intensity of At5g17165 in each compartment

    • Calculate compartment-specific concentration using volumetric measurements

• Proximity labeling approaches:

  • Generate fusion constructs of At5g17165 with compartment-specific targeting signals

  • Engineer TurboID or APEX2 proximity labeling tags

  • Identify compartment-specific interaction partners through mass spectrometry

• Reporter system development:

  • Create split fluorescent protein systems with compartment-anchored components

  • Develop FRET sensors for detecting conformational changes in different compartments

  • Implement optogenetic tools for tracking dynamic relocalization

• Data integration and modeling:

  • Combine multiple methodologies to cross-validate findings

  • Develop mathematical models of protein trafficking between compartments

  • Correlate subcellular distribution with functional readouts

These approaches provide comprehensive understanding of At5g17165 localization dynamics and their functional implications.

How can CRISPR gene editing be used to validate At5g17165 antibody specificity and function?

CRISPR-based approaches offer powerful strategies for antibody validation:

• Epitope-focused mutations:

  • Design guide RNAs targeting the epitope region recognized by the antibody

  • Generate precise modifications that alter key residues within the epitope

  • Create control mutations outside the epitope region

  • Compare antibody binding between wild-type and epitope-modified plants

• Complete knockout generation:

  • Design guide RNAs targeting critical exons of At5g17165

  • Screen for frameshift mutations causing functional knockouts

  • Compare antibody signal between wild-type and knockout plants

  • Use these lines as definitive negative controls for all applications

• Epitope tagging at endogenous locus:

  • Implement homology-directed repair to introduce tags (HA, FLAG, V5)

  • Compare signal patterns between anti-At5g17165 and anti-tag antibodies

  • Generate correlation data across tissues and conditions

  • Assess functional consequences of tag introduction

• Allelic series creation:

  • Develop a range of mutations affecting different protein domains

  • Correlate antibody detection with functional phenotypes

  • Map structure-function relationships via domain-specific mutations

  • Identify regulatory regions governing expression patterns

• Conditional allele generation:

  • Create degron-tagged versions for rapid protein depletion

  • Develop tissue-specific or inducible knockout systems

  • Compare antibody signals following conditional manipulation

  • Correlate protein depletion kinetics with phenotypic consequences

These CRISPR-based resources provide essential validation tools while simultaneously advancing functional understanding of At5g17165.

What are the considerations for developing At5g17165 antibodies compatible with super-resolution microscopy techniques?

Developing antibodies optimized for super-resolution microscopy requires specialized approaches:

• Fluorophore selection criteria:

  • For STORM/PALM: Select fluorophores with appropriate blinking kinetics

  • For STED: Choose dyes with high depletion efficiency and photostability

  • For SIM: Prioritize brightness and resistance to photobleaching

  • Consider far-red fluorophores to minimize plant autofluorescence interference

• Conjugation strategies:

  • Direct conjugation to minimize linkage distance

  • Site-specific conjugation methods (sortase, click chemistry)

  • Optimized fluorophore:antibody ratio (typically 2-4 fluorophores per antibody)

  • Purification of conjugated antibodies from free dye

• Validation parameters:

  • Resolution enhancement verification using known subcellular structures

  • Quantitative assessment of localization precision

  • Comparison with conventional microscopy to confirm pattern preservation

  • Single-molecule tracking capability evaluation

• Sample preparation optimization:

  • Specialized fixation protocols to preserve nanoscale structure

  • Aggressive background reduction strategies (pre-extraction, quenching)

  • Optical clearing techniques compatible with immunolabeling

  • Expansion microscopy protocols for plant tissues

• Analysis considerations:

  • Cluster analysis methods for quantifying molecular organization

  • Colocalization at super-resolution scales (10-20 nm precision)

  • 3D reconstruction from optical sections

  • Integration with electron microscopy data (CLEM approaches)

Super-resolution imaging of At5g17165 can reveal previously undetectable spatial patterns and molecular associations within plant cells.

How can At5g17165 antibodies be integrated into high-throughput phenotypic screening platforms?

Incorporating At5g17165 antibodies into high-throughput screening workflows involves these systematic approaches:

• Assay miniaturization:

  • Adapt immunodetection to 384 or 1536-well formats

  • Develop homogeneous assay formats (no-wash TR-FRET or AlphaLISA)

  • Optimize reagent consumption (antibody dilutions of 1:2000 or higher)

  • Implement automated liquid handling compatible with plant lysates

• Signal quantification methods:

  • Fluorescence-based detection for increased sensitivity

  • Multiplex capability with orthogonal fluorophores

  • Time-resolved detection to minimize plant compound interference

  • Bioluminescence-based readouts for reduced background

• Sample preparation automation:

  • Standardized plant growth in automation-compatible formats

  • High-throughput tissue homogenization protocols

  • Protein extraction methods compatible with direct assay integration

  • Quality control metrics for extract normalization

• Screening strategy design:

  • Primary screens focusing on total At5g17165 levels

  • Secondary assays examining phosphorylation or other modifications

  • Counter-screens to eliminate false positives

  • Dose-response assessments for hit compounds

• Data analysis infrastructure:

  • Automated image analysis pipelines for cellular phenotypes

  • Machine learning approaches for complex phenotype classification

  • Statistical methods for identifying significant perturbations

  • Integration with genetic and chemical annotation databases

This approach enables screening of environmental conditions, chemical compounds, or genetic variants affecting At5g17165 expression, modification, or function in plant systems.

How can I assess cross-reactivity of At5g17165 antibodies with orthologous proteins from other plant species?

Evaluating antibody cross-reactivity across species requires systematic analysis:

• Sequence homology assessment:

  • Perform multiple sequence alignments of At5g17165 orthologs

  • Focus analysis on the antibody epitope region

  • Quantify percent identity and similarity across species

  • Identify conserved vs. variable regions within epitopes

• Predictive cross-reactivity scoring:

  • Create a table of predicted cross-reactivity based on epitope conservation:

    Species	Epitope Sequence	% Identity	Predicted Cross-reactivity
    A. thaliana	XXXXXXXX	100%	High
    B. napus	XXXX--XX	75%	Medium
    O. sativa	XX----XX	50%	Low

  • Consider charge conservation even when amino acids differ

  • Evaluate tertiary structure conservation if epitope is conformational

• Experimental validation approaches:

  • Test against recombinant proteins from multiple species

  • Evaluate tissue extracts from diverse plant lineages

  • Compare signal patterns with predicted protein expression

  • Conduct epitope mapping to identify cross-reactive determinants

• Application-specific considerations:

  • Western blot may show different cross-reactivity than immunofluorescence

  • Native conditions may preserve conformational epitopes better than denaturing

  • Titrate antibody concentrations for each species separately

  • Consider species-specific background patterns

• Documentation standards:

  • Report both positive and negative cross-reactivity results

  • Document experimental conditions for cross-reactivity testing

  • Provide recommendation for antibody use in non-model species